Alcami has acquired TriPharm Services, a new state-of-the-art sterile fill-finish manufacturing centre located near Research Triangle Park, North Carolina. The acquisition of TriPharm follows the recently announced $17 million expansion of Alcami's sterile fill-finish facility in Charleston, South Carolina.
TriPharm's facility bolsters Alcami's existing sterile fill-finish business, adding new prefilled syringe capabilities and isolator technology, while also providing incremental flexible sterile fill-finish and lyophilisation capacity to meet growing industry demand.
TriPharm is building a new manufacturing facility expected to be operational by the second half of 2020.
"Our combination with TriPharm is an important next step in the execution of Alcami's strategy to focus investments across our network to better serve rapidly growing specialised market segments," said Alcami Interim CEO, George Van Kula. "TriPharm expands our existing capabilities and provides additional equipment lines that will allow us to better serve the fast-developing biologics market segment."
"As drug makers increasingly shift their focus toward more specialised, targeted therapeutics, and current injectable drug shortages hamper patient care, sterile fill-finish operations at proper scale are highly valued," said TriPharm Co-Founder and CEO, Patrick Walsh. "Our Research Triangle Park facility is designed to address this highly specialised industry demand."
